Literature DB >> 15102770

Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.

Lisa M Harrison1, Wilhelmina C E van Haaften, Vernon L Tesh.   

Abstract

Infection with Shiga toxin (Stx)-producing bacteria and the subsequent release of Stxs and endotoxins into the bloodstream may damage blood vessels in the colon, kidneys, and central nervous system, leading to bloody diarrhea, acute renal failure, and neurological complications. The proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-1beta (IL-1beta) may contribute to the pathogenesis of Stx-induced vascular lesions by up-regulating toxin receptor expression on endothelial cells. We previously showed that macrophages treated with purified Shiga toxin 1 (Stx1) or lipopolysaccharides (LPS) secrete TNF-alpha and IL-1beta. Northern blot analysis revealed that treatment of the human monocytic cell line THP-1 with LPS induced a rapid and transient increase in steady-state TNF-alpha and IL-1beta transcripts. In contrast, Stx1 induced slower but prolonged elevations in cytokine transcripts. The presence of both stimulants resulted in optimal cytokine mRNA induction in terms of kinetics and prolonged expression. Compared to LPS, Stx1 was a poor inducer of IL-1beta protein expression, although levels of soluble IL-1beta induced by all treatments continually increased over 72 h. IL-1beta transcripts were not induced by Stx1 B-subunits. Using the transcriptional inhibitor actinomycin D, we determined that treatment with Stx1 or Stx1 plus LPS induced cytokine transcripts with increased stability compared to transcripts induced by LPS alone. For all treatments, IL-1beta mRNA decay was slower than TNF-alpha. Collectively, our data suggest that Stxs affect cytokine expression, in part, at the posttranscriptional level by stabilizing mRNAs. Optimal TNF-alpha expression occurs when both Stxs and LPS are present.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102770      PMCID: PMC387879          DOI: 10.1128/IAI.72.5.2618-2627.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis.

Authors:  A D O'Brien; V L Tesh; A Donohue-Rolfe; M P Jackson; S Olsnes; K Sandvig; A A Lindberg; G T Keusch
Journal:  Curr Top Microbiol Immunol       Date:  1992       Impact factor: 4.291

2.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.

Authors:  S K Saxena; A D O'Brien; E J Ackerman
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

3.  Role of Shiga toxin in the pathogenesis of bacillary dysentery, studied by using a Tox- mutant of Shigella dysenteriae 1.

Authors:  A Fontaine; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

5.  The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.

Authors:  T G Obrig; T P Moran; J E Brown
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

6.  A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors.

Authors:  S Harrold; C Genovese; B Kobrin; S L Morrison; C Milcarek
Journal:  Anal Biochem       Date:  1991-10       Impact factor: 3.365

7.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

8.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli.

Authors:  P E Stein; A Boodhoo; G J Tyrrell; J L Brunton; R J Read
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

View more
  34 in total

1.  Chemokine expression in the monocytic cell line THP-1 in response to purified shiga toxin 1 and/or lipopolysaccharides.

Authors:  Lisa M Harrison; Christel van den Hoogen; Wilhelmina C E van Haaften; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Global transcriptional response of macrophage-like THP-1 cells to Shiga toxin type 1.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Cristi L Galindo; Ashok K Chopra; Vernon L Tesh
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

3.  Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.

Authors:  Fadila Guessous; Marek Marcinkiewicz; Renata Polanowska-Grabowska; Sudawadee Kongkhum; Daniel Heatherly; Tom Obrig; Adrian R L Gear
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

5.  Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.

Authors:  Teresa M DesRochers; Erica Palma Kimmerling; Dakshina M Jandhyala; Wassim El-Jouni; Jing Zhou; Cheleste M Thorpe; John M Leong; David L Kaplan
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

6.  Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells.

Authors:  Dinorah Leyva-Illades; Rama P Cherla; Moo-Seung Lee; Vernon L Tesh
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

7.  Shiga toxin 1 induces apoptosis in the human myelogenous leukemia cell line THP-1 by a caspase-8-dependent, tumor necrosis factor receptor-independent mechanism.

Authors:  Sang-Yun Lee; Rama P Cherla; Isa Caliskan; Vernon L Tesh
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Differential response of the human renal proximal tubular epithelial cell line HK-2 to Shiga toxin types 1 and 2.

Authors:  Erin K Lentz; Dinorah Leyva-Illades; Moo-Seung Lee; Rama P Cherla; Vernon L Tesh
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 9.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

Review 10.  Herbal medicinal products target defined biochemical and molecular mediators of inflammatory autoimmune arthritis.

Authors:  Shivaprasad H Venkatesha; Brian M Berman; Kamal D Moudgil
Journal:  Bioorg Med Chem       Date:  2010-10-31       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.